Sanofi-Aventis to Trim Sales Force
French drugmaker to cut 800 jobs, joining the long list of companies restructuring to make ends meet.
Roche Touts Positive Data for Investigational Diabetes Drug
Swiss pharma giant Roche was abuzz at ADA, announcing that its new diabetes treatment is set for Phase III trials and commenting on future plans for failed CETP inhibitor dalcetrapib.
